Adiponectin, Leptin, and Resistin Are Dysregulated in Patients Infected by SARS-CoV-2
暂无分享,去创建一个
G. Signoriello | F. Scialò | A. Bianco | A. Daniele | E. Nigro | Marta Mallardo | V. D’Agnano | F. Perrotta
[1] L. Joosten,et al. Adipocytokine plasma concentrations reflect influence of inflammation but not body mass index (BMI) on clinical outcomes of COVID‐19 patients: A prospective observational study from the Netherlands , 2022, Clinical obesity.
[2] F. Scialò,et al. Exploring the Role of Krebs von den Lungen-6 in Severe to Critical COVID-19 Patients , 2022, Life.
[3] D. Okuzaki,et al. Resistin Associated With Cytokines and Endothelial Cell Adhesion Molecules Is Related to Worse Outcome in COVID-19 , 2022, Frontiers in Immunology.
[4] P. Puthanveetil,et al. The Head-to-Toe Hormone: Leptin as an Extensive Modulator of Physiologic Systems , 2022, International journal of molecular sciences.
[5] X. Terra,et al. Resistin and IL-15 as Predictors of Invasive Mechanical Ventilation in COVID-19 Pneumonia Irrespective of the Presence of Obesity and Metabolic Syndrome , 2022, Journal of personalized medicine.
[6] Sofi Beaula Winfred,et al. Mechanisms contributing to adverse outcomes of COVID-19 in obesity , 2022, Molecular and Cellular Biochemistry.
[7] Andinet B Gizaw,et al. Overweight and obesity as risk factors for COVID-19-associated hospitalisations and death: systematic review and meta-analysis , 2022, BMJ nutrition, prevention & health.
[8] N. D’Orazio,et al. COVID-19 and Obesity: Overlapping of Two Pandemics , 2021, Obesity Facts.
[9] M. Bhat,et al. Resistin: A journey from metabolism to cancer , 2021, Translational oncology.
[10] Prince Sebastian,et al. COVID-19 Severity in Obesity: Leptin and Inflammatory Cytokine Interplay in the Link Between High Morbidity and Mortality , 2021, Frontiers in Immunology.
[11] F. Scialò,et al. SARS-CoV-2: One Year in the Pandemic. What Have We Learned, the New Vaccine Era and the Threat of SARS-CoV-2 Variants , 2021, Biomedicines.
[12] Brad J. Wood,et al. Remarkable vessel enlargement within lung consolidation in COVID-19 compared to AH1N1 pneumonia: A retrospective study in Italy , 2021, Heliyon.
[13] A. De Luca,et al. Adiponectin and Sarcopenia: A Systematic Review With Meta-Analysis , 2021, Frontiers in Endocrinology.
[14] G. Frühbeck,et al. Obesity as an adipose tissue dysfunction disease and a risk factor for infections – Covid-19 as a case study , 2021, European Journal of Internal Medicine.
[15] I. Benedek,et al. Systemic Inflammation and COVID-19 Mortality in Patients with Major Noncommunicable Diseases: Chronic Coronary Syndromes, Diabetes and Obesity , 2021, Journal of clinical medicine.
[16] Karin de Punder,et al. Obesity as a Risk Factor for Severe COVID-19 and Complications: A Review , 2021, Cells.
[17] J. Patrie,et al. Reduced adiponectin levels in patients with COVID‐19 acute respiratory failure: A case‐control study , 2021, Physiological reports.
[18] S. Kuperberg,et al. The Role of Obesity in the Immunopathogenesis of COVID-19 Respiratory Disease and Critical Illness , 2021, American journal of respiratory cell and molecular biology.
[19] J. Miller,et al. Acute Symptoms of Mild to Moderate COVID-19 Are Highly Heterogeneous Across Individuals and Over Time , 2021, Open forum infectious diseases.
[20] P. Sbraccia,et al. Susceptibility and Severity of Viral Infections in Obesity: Lessons from Influenza to COVID-19. Does Leptin Play a Role? , 2021, International journal of molecular sciences.
[21] U. P. Flato,et al. Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions , 2021, International journal of molecular sciences.
[22] P. Lai. 2019 (COVID‐19) and 2021 , 2021, Surgical practice.
[23] Beizhong Liu,et al. Leptin correlates with monocytes activation and severe condition in COVID-19 patients , 2021, Journal of leukocyte biology.
[24] W. Koh,et al. Adipokines and the risk of active TB: a nested case-control study. , 2021, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[25] F. Scialò,et al. Adiponectin is Associated with Neutrophils to Lymphocyte Ratio in Patients with Chronic Obstructive Pulmonary Disease , 2020, COPD.
[26] F. Scialò,et al. Metabolic Perturbations and Severe COVID-19 Disease: Implication of Molecular Pathways , 2020, International journal of endocrinology.
[27] Thi Mong Diep Nguyen. Adiponectin: Role in Physiology and Pathophysiology , 2020, International journal of preventive medicine.
[28] M. van Meurs,et al. Leptin levels in SARS-CoV-2 infection related respiratory failure: A cross-sectional study and a pathophysiological framework on the role of fat tissue , 2020, Heliyon.
[29] A. Malavazos,et al. COVID‐19 Rise in Younger Adults with Obesity: Visceral Adiposity Can Predict the Risk , 2020, Obesity.
[30] M. Matera,et al. Implications of the Adiponectin System in Non-Small Cell Lung Cancer Patients: A Case-Control Study , 2020, Biomolecules.
[31] F. Perrotta,et al. COVID-19 and coagulative axis: review of emerging aspects in a novel disease. , 2020, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.
[32] Eun Ji Kim,et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. , 2020, JAMA.
[33] H. Wunsch,et al. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) , 2020, Critical care medicine.
[34] E. Hoffman,et al. Associations of Serum Adipokines with Subclinical Interstitial Lung Disease Among Community-Dwelling Adults: the MESA study. , 2019, Chest.
[35] M. Caraglia,et al. The anti-proliferative effects of adiponectin on human lung adenocarcinoma A549 cells and oxidative stress involvement. , 2019, Pulmonary pharmacology & therapeutics.
[36] M. Matera,et al. The burden of obesity in asthma and COPD: Role of adiponectin. , 2017, Pulmonary pharmacology & therapeutics.
[37] G. E. Carpagnano,et al. Evaluation of adiponectin profile in Italian patients affected by obstructive sleep apnea syndrome. , 2016, Pulmonary pharmacology & therapeutics.
[38] C. Costagliola,et al. New Insight into Adiponectin Role in Obesity and Obesity-Related Diseases , 2014, BioMed research international.
[39] T. Tsao. Assembly of adiponectin oligomers , 2014, Reviews in Endocrine and Metabolic Disorders.
[40] Kazuto Nakamura,et al. Adipokines: a link between obesity and cardiovascular disease. , 2014, Journal of cardiology.
[41] Kazuto Nakamura,et al. Adiponectin Attenuates Lipopolysaccharide-Induced Acute Lung Injury through Suppression of Endothelial Cell Activation , 2012, The Journal of Immunology.
[42] K. Vuolteenaho,et al. Adipokine resistin predicts anti-inflammatory effect of glucocorticoids in asthma , 2011, Journal of Inflammation.
[43] E. Hoffman,et al. Associations of Serum Adipokines With Subclinical Interstitial Lung Disease Among Community-Dwelling Adults The Multi-Ethnic Study of Atherosclerosis (MESA) , 2020 .
[44] Limin Peng,et al. Resistin is elevated in cystic fibrosis sputum and correlates negatively with lung function. , 2019, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.